scholarly journals Beneficial effects of the novel cholecystokinin agonist (pGlu-Gln)-CCK-8 in mouse models of obesity/diabetes

Diabetologia ◽  
2012 ◽  
Vol 55 (10) ◽  
pp. 2747-2758 ◽  
Author(s):  
N. Irwin ◽  
P. Frizelle ◽  
I. A. Montgomery ◽  
R. C. Moffett ◽  
F. P. M. O’Harte ◽  
...  
2017 ◽  
Vol 58 (5) ◽  
pp. 821-826 ◽  
Author(s):  
Liqiang Li ◽  
Yue Wu ◽  
Zihua Wang ◽  
Bing Jia ◽  
Zhiyuan Hu ◽  
...  

Cephalalgia ◽  
1990 ◽  
Vol 10 (5) ◽  
pp. 207-212 ◽  
Author(s):  
Malcolm Skingle ◽  
Phillip J Birch ◽  
Glynnis E Leighton ◽  
Patrick PA Humphrey

The present study attempts to determine whether the novel anti-migraine drug sumatriptan has antinociceptive activity in rodents. Sumatriptan had little or no antinociceptive activity against a range of noxious stimuli and we therefore conclude that it is unlikely that the beneficial effects of the drug in treating migraine are due to a non-specific analgesic action.


2021 ◽  
Vol 15 ◽  
Author(s):  
Cesar Sierra ◽  
Ilario De Toma ◽  
Lorenzo Lo Cascio ◽  
Esteban Vegas ◽  
Mara Dierssen

The use of mouse models has revolutionized the field of Down syndrome (DS), increasing our knowledge about neuropathology and helping to propose new therapies for cognitive impairment. However, concerns about the reproducibility of results in mice and their translatability to humans have become a major issue, and controlling for moderators of behavior is essential. Social and environmental factors, the experience of the researcher, and the sex and strain of the animals can all have effects on behavior, and their impact on DS mouse models has not been explored. Here we analyzed the influence of a number of social and environmental factors, usually not taken into consideration, on the behavior of male and female wild-type and trisomic mice (the Ts65Dn model) in one of the most used tests for proving drug effects on memory, the novel object recognition (NOR) test. Using principal component analysis and correlation matrices, we show that the ratio of trisomic mice in the cage, the experience of the experimenter, and the timing of the test have a differential impact on male and female and on wild-type and trisomic behavior. We conclude that although the NOR test is quite robust and less susceptible to environmental influences than expected, to obtain useful results, the phenotype expression must be contrasted against the influences of social and environmental factors.


2019 ◽  
Vol 234 (9) ◽  
pp. 14896-14905 ◽  
Author(s):  
Gaohua Li ◽  
Hua Liu ◽  
Chunlian Ma ◽  
Yanfang Chen ◽  
Jinju Wang ◽  
...  

2017 ◽  
Author(s):  
yuji piao ◽  
Craig Thomas ◽  
Verlene Henry ◽  
Ningyi Tiao ◽  
Soon Young park ◽  
...  

2003 ◽  
Vol 4 (2) ◽  
pp. 156
Author(s):  
L. Millatt ◽  
K. Bertrand ◽  
R. Darteil ◽  
P. Verwaerde ◽  
D.W. Hum ◽  
...  

2011 ◽  
Vol 17 (2) ◽  
pp. 532-542 ◽  
Author(s):  
Sundaram Ramasamy ◽  
Deanna D. Nguyen ◽  
Michelle A. Eston ◽  
Sayeda Nasrin Alam ◽  
Angela K. Moss ◽  
...  

2018 ◽  
Vol 315 (1) ◽  
pp. F57-F73
Author(s):  
Katy Billot ◽  
Charlène Coquil ◽  
Benoit Villiers ◽  
Béatrice Josselin-Foll ◽  
Nathalie Desban ◽  
...  

Following the discovery of (R)-roscovitine’s beneficial effects in three polycystic kidney disease (PKD) mouse models, cyclin-dependent kinases (CDKs) inhibitors have been investigated as potential treatments. We have used various affinity chromatography approaches to identify the molecular targets of roscovitine and its more potent analog (S)-CR8 in human and murine polycystic kidneys. These methods revealed casein kinases 1 (CK1) as additional targets of the two drugs. CK1ε expression at the mRNA and protein levels is enhanced in polycystic kidneys of 11 different PKD mouse models as well as in human polycystic kidneys. A shift in the pattern of CK1α isoforms is observed in all PKD mouse models. Furthermore, the catalytic activities of both CK1ε and CK1α are increased in mouse polycystic kidneys. Inhibition of CK1ε and CK1α may thus contribute to the long-lasting attenuating effects of roscovitine and (S)-CR8 on cyst development. CDKs and CK1s may constitute a dual therapeutic target to develop kinase inhibitory PKD drug candidates.


2021 ◽  
Vol 13 (2) ◽  
pp. 760-765
Author(s):  
Anamika Chauhan

This review aimed to focus on using foods to boost immunity against COVID-19 in all age groups. In human, coronavirus causes the common cold, severe acute respiratory syndrome (SARS), and a major threat to public health. The novel coronavirus was declared a pandemic by the World Health Organization due to its rapid infectivity. COVID-19 infection is most probably reported in people with low immunity response. The nutrients, which show beneficial effects on the immune system, are called immune nutrients and diet is called immune diet. A healthy diet can reduce the risk of infection of COVID-19 and can prevent disease. Nutritional food intake is also necessary for people with chronic illness, obese persons, diabetes, cardiovascular disease, cognitive dysfunction like anxiety and depression. All nutrients are essential for maintaining immunity and providing appropriate amounts of protein, fat, carbohydrate, vitamins, and minerals for the surveillance mode of keeping us from getting sick. The use of plenty of water, minerals such as micronutrients, zinc, copper, selenium, iron, magnesium, food rich in vitamins, and a good lifestyle can promote health and overwhelm this coronavirus infection.


Sign in / Sign up

Export Citation Format

Share Document